| Name | microRNA 5700 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have established that ASB15, a member of the ankyrin repeat and SOCS box protein family predominantly expressed in skeletal muscle, plays an important role in regulating muscle growth. Overexpression of fullālength ASB15 in myoblasts was shown to delay differentiation initially, followed by a significant increase in protein synthesis that ultimately leads to enhanced muscle fiber growth in vivo. Mutational analyses further revealed that removal of specific functional domains of ASB15 either dysregulated protein degradation or led to abnormal differentiation, underscoring its dual role in governing both protein turnover and myoblast development."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nIn parallel, investigations into the signal transduction pathways modulated by ASB15 have revealed its impact on the PI3K/Akt pathway during early muscle cell differentiation. Specifically, myoblasts overexpressing ASB15 exhibited reduced Akt phosphorylation, which correlated with delayed differentiation, whereas attenuation of ASB15 expression enhanced Akt activation and accelerated differentiation. Pharmacologic modulation using IGF-I and PI3K/Akt-specific inhibitors further supported these findings, suggesting that ASB15 exerts its regulatory effects on muscle cell differentiation predominantly via modulation of the PI3K/Akt axis, rather than via the Erk1/2 pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, the findings from these studies illuminate a critical role for ASB15 in muscle development, integrating the regulation of protein synthesis, degradation, and differentiation through distinct molecular pathways. By fine-tuning key signaling events such as those mediated by PI3K/Akt, ASB15 emerges as an important contributor to skeletal muscle growth, with potential implications for therapeutic strategies aimed at combating muscle wasting disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "T G McDaneld, K Hannon, D E Moody "}, {"type": "b", "children": [{"type": "t", "text": "Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Regul Integr Comp Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpregu.00239.2005"}], "href": "https://doi.org/10.1152/ajpregu.00239.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16424087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16424087"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "T G McDaneld, D M Spurlock "}, {"type": "b", "children": [{"type": "t", "text": "Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Anim Sci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2527/jas.2008-1076"}], "href": "https://doi.org/10.2527/jas.2008-1076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18641171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18641171"}]}]}]}
|
| NCBI Gene ID | 100847031 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR5700 has 171 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 4 datasets.
Click the + buttons to view associations for MIR5700 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR5700 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR5700 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR5700 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR5700 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |